Table 8.
Outcome | End User Type* | ||||
---|---|---|---|---|---|
BI | CL | ED | RG | ||
Short-term | Awareness of ongoing research | √ | √ | √ | √ |
Policy assessments | √ | √ | |||
Monitoring and surveillance | √ | √ | √ | ||
Communities of science | √ | √ | √ | √ | |
Replication and new research | √ | √ | √ | ||
Commercial products and drugs | √ | √ | √ | √ | |
Awareness of environmental health impacts and proposed regulations | √ | √ | √ | √ | |
Public awareness | √ | √ | √ | √ | |
Intermediate | Identification of scientific needs/new science | √ | √ | √ | √ |
Laws, regulations, and standards | √ | √ | √ | √ | |
Guidelines and recommendations | √ | √ | √ | √ | |
Accumulation of knowledge | √ | √ | √ | √ | |
Operations change to reduce environmental hazards | √ | ||||
Knowledge and attitude change | √ | √ | √ | √ | |
Long-term | New grant programs | √ | |||
Improved environment | √ | √ | √ | √ | |
Reduced human exposure to environmental hazards | √ | √ | √ | √ | |
Clinical practice changes | √ | √ | √ | ||
Reduced emissions | √ | ||||
Public behavior change and advocacy | √ | √ | √ |
Business and Industry [BI], Clinical [CL], Education and Advocacy [ED], Regulators [RG]
√ Indicates that at least one end user in this category provided information relative to the outcome, tracing one or more pathway